Business
CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call
DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ: MDAI), the reporting date of the financial results for the fourth quarter was incorrectly stated, and has been amended. The corrected release follows: Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and use
About this update from Spectral Ai, Inc.
[{"type":"image","alt":"Spectral AI, Inc.","displaySize":"","headline":null,"caption":"Spectral AI, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":150,"height":78,"url":"https://media.zenfs.com/en/globenewswire.com/23a9fc91c43a2f0647ed42a9076103ab"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NMHcc5qGUB2OTcJyeAvzUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/23a9fc91c43a2f0647ed42a9076103ab","width":150,"height":78}},"lazy":false},{"type":"text","content":"DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ: MDAI), the reporting date of the financial results for the fourth quarter was incorrectly stated, and has been amended. The corrected release follows:","length":280,"tagName":"p"},{"type":"text","content":"Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, March 27, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results.","length":578,"tagName":"p"},{"type":"text","content":"Investors interested in participating in the live call can dial:","length":64,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"844-481-3008 - U.S.","length":19,"tagName":"p"}]},{"val":[{"type":"text","content":"412-317-1892 - International","length":28,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":47,"olType":false},{"type":"text","content":"A simultaneous webcast of the call may be accessed online from the Events & Presentations section of the Investor Relations page of the Company’s website at https://investors.spectral-ai.com/news-events/events.","length":214,"tagName":"p"},{"type":"text","content":"About Spectral AI","length":17,"tagName":"p"},{"type":"text","content":"Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound car...